The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Hepatocellular Carcinoma in Patients With No Identifiable Risk Factors
(Oxford). 2020 Jun 23;S1365-182X(20)31020-0. doi: 10.1016/j.hpb.2020.05.005.Online ahead of print.
Caitlin A McIntyre1, Joanne F Chou2, Mithat Gonen2, Jinru Shia3, Maya Gambarin-Gelwan4, Vinod P Balachandran1, T Peter Kingham1, Peter J Allen1, Jeffrey A Drebin1, William R Jarnagin1, Michael I D'Angelica5
Author information
1Department of Surgery, Hepatopancreatobiliary Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
2Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
3Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
4Department of Medicine, Gastroenterology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
5Department of Surgery, Hepatopancreatobiliary Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: dangelim@mskcc.org.
Abstract
Background: A subset of patients have no risk factors for the development of hepatocellular carcinoma (HCC). We evaluated differences in clinical variables between patients with and without risk factors who underwent surgical resection.
Methods: A prospectively maintained database was queried for patients who underwent R0/R1 resection of HCC between 1992 and 2016. Risk factors included HCV, HBV, hemochromatosis, alcoholic liver disease, or cirrhosis, stage 2 or 3 fibrosis or severe (>66%) steatosis of the non-neoplastic liver. Variables were compared between patients with and without risk factors.
Results: There were 416 patients who underwent resection; 276 (66%) had known risk factors while 140 (34%) did not. Patients without risk factors were more likely to be older, female and have hyperlipidemia or coronary artery disease (p < 0.004). These patients had larger tumors and were more likely to undergo major hepatectomy (p < 0.001). There was no difference in OS (5-year, 56% vs 47%, p = 0.335), RFS (27% vs 24%, p = 0.398), or the rates of intrahepatic (HR:1.16 [95%CI:0.95-1.57], p = 0.344) and extrahepatic recurrences (HR:0.72 [95%CI:0.4-1.3], p = 0.261) between groups.
Conclusion: Patients without risk factors for HCC presented with larger tumors yet had similar outcomes, suggesting these tumors may represent a different disease process, and underlying liver dysfunction can influence overall outcome.